All VV116 articles
-
NewsWHO updates its guidance on treatments for COVID-19
The new recommendations reflect the evolving nature of the virus and the changing role of Covid-19 therapies.
-
NewsTwo Chinese anti-SARS-CoV-2 drugs conditionally approved for marketing
Two innovative Chinese oral anti-SARS-CoV-2 drugs, Xiannuoxin (simnotrelvir/ritonavir) and VV116 (deuremidevir hydrobromide), were conditionally approved for marketing by China’s National Medical Products Administration (NMPA) in late January after urgent review and approval under the Special Examination and Approval of Drugs Policy.
